Madaswamy S. Muthu

M.S. Muthu (born 20 July 1981) is a Pharmaceutical engineer, Scientist, Inventor and one of the twenty Institute Professors at the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi, India. He is a researcher in the fields of nanomedicine, targeted drug delivery, and in theranostics nanomedicine for imaging and therapy.

Background and personal life
Dr. Muthu completed his Ph.D. research work under the supervision of Prof. Sanjay Singh from the Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India. He has done his post-doctoral research in cancer nanotechnology under the supervision of Prof. Feng Si-Shen from the National University of Singapore in 2010 & 2014 (2yrs). Dr. Muthu is a Professor of Pharmaceutics in the Department of Pharmaceutical Engineering & Technology, IIT(BHU).

Contributions to nanomedicine and drug delivery
He is a widely recognized and cited researcher in drug delivery especially in the fields of nanotechnology and theranostics. He has published more than 120 research articles in peer-reviewed national and international journals. His research work is mainly focused on targeted nanomedicine and/or nanotheranostic drug delivery of anti-cancer agents, antipsychotics, antithrombotics and antimicrobials. He is an editor in chief for the international peer-reviewed journal  Research & Reviews: Journal of Pharmacology and Toxicological Studies . Additionally, he is the editorial board member of the "Diagnostics and Therapeutics" Journal published by Luminescience press is based in Hong Kong with offices in Wuhan and Xi’an, China. He is among the top 2% scientist globally, list compiled by the Stanford University. His profile has been listed at the 6th rank in IIT BHU as per Adscientific index.

Awards and honors
Muthu received various scientific awards from government and non-government organization including the BOYSCAST Fellowship, Academic Excellence Award, CREST Award, IMS-Research Publication Award, BHU Vice-Chancellor's Medical Research Award, International Faculty Award, and Best Young Scientist Award. He is the recipient of the BIRAC-DBT-Gandhian Young Technological Innovation (GYTI) Award in 2017, from the President of India for advancing nanomedicine research. His research work has secured Rs. 2.19 crores funds from various government funding agencies, which includes SERB, DST, DBT, ICMR, and BIRAC. He has been elected as a Member of the National Academy of Sciences (NASI), India in 2019. Additionally, he is a fellow of the Royal Society of Chemistry (FRSC). Recently, he has developed targeted nanomedicine for breast cancer therapy with reduced systemic toxicity, which has successfully demonstrated its efficacy in preclinical studies.